|
|
|
市場調查報告書
胰島素給藥設備:全球開發平台分析機會評估及與到2017年為止的市場預測
Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
| 出版商 |
GlobalData |
| 出版日期 |
2012年01月 |
商品編碼 |
227854 |
| 內容資訊 |
英文 Pages: 104 |
| 價格 |
|
|
胰島素給藥設備:全球開發平台分析機會評估及與到2017年為止的市場預測 是由出版商GlobalData在2012年01月所出版的。
這份英文市場調查報告書包含Pages: 104 價格從美金3995起跳。
本報告提供全球胰島素給藥設備市場主要資料，提供資訊與分析，市場情況，競爭情形，市場趨勢，市場動態，技術趨勢和主要企業簡介等資訊，為您概述為以下內容。
第1章 目錄
第2章 簡介
第3章 疾病概要:糖尿病
第4章 胰島素給藥設備:概要
- 市場區分
- 胰島素筆
- 胰島素幫浦
- 胰島素注射器
- 傳統胰島素幫浦配件
- 胰島素給藥設備比較
第5章 胰島素給藥設備:全球市場特徵
- 收益實際成果 - 2003∼2010年
- 收益預測 - 2010∼2017年
- 主要趨勢
- 市場動態
第6章 全球胰島素給藥設備市場:不同市場區隔分析
- 胰島素筆的收益實際成果 - 2003∼2010年
- 胰島素筆的收益預測 - 2010∼2017年
- 胰島素幫浦的收益實際成果 - 2003∼2010年
- 胰島素幫浦的收益預測 - 2010∼2017年
- 胰島素注射器的收益實際成果 - 2003∼2010年
- 胰島素注射器的收益預測 - 2010∼2017年
- 傳統胰島素幫浦配件的收益實際成果 - 2003∼2010年
- 傳統胰島素幫浦配件的收益預測 - 2010∼2017年
第7章 各國的胰島素給藥設備市場上收益(2003∼2017年)
- 收益實際成果 - 美國:2003∼2010年
- 收益預測 - 美國:2010∼2017年
- 收益實際成果 - 加拿大:2003∼2010年
- 收益預測 - 加拿大:2010∼2017年
- 收益實際成果 - 英國:2003∼2010年
- 收益預測 - 英國:2010∼2017年
- 收益實際成果 - 德國:2003∼2010年
- 收益預測 - 德國:2010∼2017年
- 收益實際成果 - 法國:2003∼2010年
- 收益預測 - 法國:2010∼2017年
- 收益實際成果 - 義大利:2003∼2010年
- 收益預測 - 義大利:2010∼2017年
- 收益實際成果 - 西班牙:2003∼2010年
- 收益預測 - 西班牙:2010∼2017年
- 收益實際成果 - 日本:2003∼2010年
- 收益預測 - 日本:2010∼2017年
- 收益實際成果 - 中國:2003∼2010年
- 收益預測 - 中國:2010∼2017年
- 收益實際成果 - 印度:2003∼2010年
- 收益預測 - 印度:2010∼2017年
- 收益實際成果 - 澳洲:2003∼2010年
- 收益預測 - 澳洲:2010∼2017年
- 收益實際成果 - 巴西:2003∼2010年
- 收益預測 - 巴西:2010∼2017年
第8章 胰島素給藥設備的主要企業
- 主要企業
- Medtronic Inc.
- Novo Nordisk A/S
- Sanofi
- Eli Lilly and Company
- Becton, Dickinson and Company
- F. Hoffmann-La Roche Ltd. (Disetronic Medical Systems AG)
第9章 胰島素給藥設備:開發平台評估
- 各開發階段的開發中產品:2011年
- 開發階段及各領域的開發平台評估:2011年
第10章 胰島素給藥設備市場上策略性交易分析
第11章 附錄
圖表
Abstract
Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Summary
GlobalData's new report, "Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global insulin delivery devices market. The report provides market landscape, competitive landscape and market trends information on the insulin delivery devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market's dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Insulin Pens, Insulin Pumps, Insulin Syringes and Traditional Insulin Pump Accessories.
- Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints within the insulin delivery devices market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Medtronic, Novo Nordisk, Sanofi, Eli Lilly and Company, Becton, Dickinson and Company and F. Hoffmann-La Roche Ltd.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the insulin delivery devices globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- What's the next big thing in the insulin delivery devices market landscape? - Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global insulin delivery devices market and the factors shaping it.
TOC
1 Table of Contents
1 Table of Contents 3
- 1.1 List of Tables 5
- 1.2 List of Figures 6
2 Introduction 8
- 2.1 GlobalData Report Guidance 8
3 Disease Overview - Diabetes 9
- 3.1 Types of Diabetes 9
- 3.1.1 Type 1 Diabetes 9
- 3.1.2 Type 2 Diabetes 9
- 3.1.3 Gestational Diabetes 9
- 3.2 Signs and Symptoms 9
- 3.3 Diagnosis 10
- 3.3.1 Fasting Plasma Glucose Test 10
- 3.3.2 Oral Glucose Tolerance Test 10
- 3.3.3 Random Plasma Glucose Test 10
- 3.4 Epidemiology 11
- 3.4.1 Epidemiology of Diabetes in the US 12
- 3.4.2 Epidemiology of Diabetes in the UK 12
- 3.4.3 Epidemiology of Diabetes in Japan 12
- 3.4.4 Epidemiology of Diabetes in India 12
- 3.4.5 Epidemiology of Diabetes in China 12
4 Insulin Delivery Devices - Overview 13
- 4.1 Insulin Delivery Devices, Market Segmentation 13
- 4.1.1 Insulin Pen 13
- 4.1.2 Insulin Pump 14
- 4.1.3 Insulin Syringe 14
- 4.1.4 Traditional Insulin Pump Accessories 14
- 4.2 Comparison of Insulin Delivery Devices 15
5 Insulin Delivery Devices - Global Market Characterization 16
- 5.1 Insulin Delivery Devices Market, Global, Revenue ($bn), Historic, 2003-2010 16
- 5.2 Insulin Delivery Devices Market, Global, Revenue ($bn), Forecast, 2010-2017 17
- 5.3 Global Insulin Delivery Devices Market, Key Trends 18
- 5.3.1 More People Use Insulin Pumps in the US than in European Countries, where Insulin Pens are the Preferred Choice 18
- 5.3.2 Disposable Insulin Pumps to Gain Market Share at the Expense of Traditional Insulin Pumps 18
- 5.3.3 Partnerships between Insulin Manufacturers and Insulin Delivery Devices Companies is a Recent Trend in the Insulin Delivery Devices Market 19
- 5.3.4 Food and Drug Administration to Tighten the Regulation of Infusion Pumps 20
- 5.3.5 Co-Marketing of Insulin Pumps with Blood Glucose Monitoring/Continuous Glucose Monitor Devices is a Recent Market Trend 21
- 5.3.6 Artificial Pancreas to be a Future Trend in the Insulin Pumps Market 21
- 5.4 Global Insulin Delivery Devices, Market Dynamics 24
- 5.4.1 Market Drivers 24
- 5.4.2 Market Restraints 27
6 Global Insulin Delivery Devices Market - Analysis by Segment 29
- 6.1 Insulin Pens, Global, Revenue ($m), Historic, 2003-2010 29
- 6.2 Insulin Pens, Global, Revenue ($m), Forecast, 2010-2017 30
- 6.2.1 Market Drivers 31
- 6.2.2 Market Restraints 33
- 6.3 Insulin Pumps, Global, Revenue ($m), Historic, 2003-2010 34
- 6.4 Insulin Pumps, Global, Revenue ($m), Forecast, 2010-2017 35
- 6.4.1 Market Drivers 36
- 6.4.2 Market Restraints 37
- 6.5 Insulin Syringes, Global, Revenue ($m), Historic, 2003-2010 38
- 6.6 Insulin Syringes, Global, Revenue ($m), Forecast, 2010-2017 39
- 6.6.1 Market Drivers 40
- 6.6.2 Market Restraints 40
- 6.7 Traditional Insulin Pump Accessories, Global, Revenue ($bn), History, 2003-2010 41
- 6.8 Traditional Insulin Pump Accessories, Global, Revenue ($bn), Forecast, 2010-2017 42
7 Insulin Delivery Devices Market - Analysis and Forecasts by Country, Revenue ($m), 2003-2017 43
- 7.1 Insulin Delivery Devices Market, The US, Revenue ($m), Historic, 2003-2010 43
- 7.2 Insulin Delivery Devices Market, The US, Revenue ($m), Forecast, 2010-2017 44
- 7.3 Insulin Delivery Devices Market, Canada, Revenue ($m), Historic, 2003-2010 45
- 7.4 Insulin Delivery Devices Market, Canada, Revenue ($m), Forecast, 2010-2017 46
- 7.5 Insulin Delivery Devices Market, The UK, Revenue ($m), Historic, 2003-2010 50
- 7.6 Insulin Delivery Devices Market, The UK, Revenue ($m), Forecast, 2010-2017 51
- 7.7 Insulin Delivery Devices Market, Germany, Revenue ($m), Historic, 2003-2010 52
- 7.8 Insulin Delivery Devices Market, Germany, Revenue ($m), Forecast, 2010-2017 53
- 7.9 Insulin Delivery Devices Market, France, Revenue ($m), Historic, 2003-2010 54
- 7.10 Insulin Delivery Devices Market, France, Revenue ($m), Forecast, 2010-2017 55
- 7.11 Insulin Delivery Devices Market, Italy, Revenue ($m), Historic, 2003-2010 56
- 7.12 Insulin Delivery Devices Market, Italy, Revenue ($m), Forecast, 2010-2017 57
- 7.13 Insulin Delivery Devices Market, Spain, Revenue ($m), Historic, 2003-2010 58
- 7.14 Insulin Delivery Devices Market, Spain, Revenue ($m), Forecast, 2010-2017 59
- 7.15 Insulin Delivery Devices Market, Japan, Revenue ($m), Historic, 2003-2010 60
- 7.16 Insulin Delivery Devices Market, Japan, Revenue ($m), Forecast, 2010-2017 61
- 7.17 Insulin Delivery Devices Market, China, Revenue ($m), Historic, 2003-2010 62
- 7.18 Insulin Delivery Devices Market, China, Revenue ($m), Forecast, 2010-2017 63
- 7.19 Insulin Delivery Devices Market, India, Revenue ($'000), Historic, 2003-2010 64
- 7.20 Insulin Delivery Devices Market, India, Revenue ($'000), Forecast, 2010-2017 65
- 7.21 Insulin Delivery Devices Market, Australia, Revenue ($m), Historic, 2003-2010 66
- 7.22 Insulin Delivery Devices Market, Australia, Revenue ($m), Forecast, 2010-2017 67
- 7.23 Insulin Delivery Devices Market, Brazil, Revenue ($m), Historic, 2003-2010 68
- 7.24 Insulin Delivery Devices Market, Brazil, Revenue ($m), Forecast, 2010-2017 69
8 Global Insulin Delivery Devices Market - Competitive Assessment 70
- 8.1 Insulin Delivery Devices Market, Global, Key Company Share (%), 2010 70
- 8.2 Insulin Delivery Devices, Global, Key Market Participants 71
- 8.2.1 Medtronic Inc. 71
- 8.2.2 Novo Nordisk A/S 73
- 8.2.3 Sanofi 75
- 8.2.4 Eli Lilly and Company 77
- 8.2.5 Becton, Dickinson and Company 78
- 8.2.6 F. Hoffmann-La Roche Ltd. (Disetronic Medical Systems AG) 80
9 Insulin Delivery Devices - Pipeline Assessment 81
- 9.1 Insulin Delivery Devices, Pipeline Products by Stage of Development, 2011 81
- 9.2 Pipeline Assessment by Developmental Stage and Territory, 2011 82
- 9.2.1 Insulin Pumps, Pipeline Assessment by Developmental Stage, 2011 82
- 9.2.2 Key Pipeline Products, Insulin Pumps 84
- 9.2.3 Insulin Pens, Pipeline by Developmental Stage and Territory, 2011 92
- 9.2.4 Key Pipeline Products, Insulin Pens 92
- 9.2.5 Insulin Syringes, Pipeline by Developmental Stage and Territory, 2011 93
- 9.2.6 Other Insulin Delivery Devices, Pipeline by Developmental Stage and Territory, 2011 93
- 9.2.7 Key Pipeline Products, Other Insulin Delivery Devices 94
10 Global Insulin Delivery Devices Market - Strategic Deals Analysis 96
- 10.1 Key Deals, Insulin Delivery Devices Market 96
- 10.1.1 Haselmeier Enters into Distribution Agreement with Biocon 96
- 10.1.2 Cellnovo Enters into Technology Integration Agreement with LifeScan 96
- 10.1.3 Insulet Announces Acquisition of Neighborhood Diabetes 97
- 10.1.4 Insulet Enters into Distribution Agreement with GlaxoSmithKline 97
- 10.1.5 Cellnovo Enters into Agreement with Home Diagnostics 97
- 10.1.6 Roche Holding Acquires Medingo from Elron Electronic Industries 97
- 10.1.7 JDRF Enters into Agreement with Becton, Dickinson and Company 98
- 10.1.8 Insulet Enters into Distribution Agreement with Ypsomed Holding 98
11 Appendix 99
- 11.1 Market Definitions 99
- 11.1.1 Insulin Delivery Devices 99
- 11.2 Abbreviations 100
- 11.3 Research Methodology 102
- 11.3.1 Secondary Research 102
- 11.3.2 Primary Research 102
- 11.3.3 Models 103
- 11.3.4 Forecasts 103
- 11.3.5 Expert Panel 103
- 11.4 GlobalData Consulting 103
- 11.5 Contact Us 103
- 11.6 Disclaimer 104
- 11.7 Sources 104
List of Tables
1.1 List of Tables
- Table 1: Fasting Plasma Glucose Test 10
- Table 2: Oral Glucose Tolerance Test 10
- Table 3: Oral Glucose Tolerance Test for Gestational Diabetes 10
- Table 4: Diabetes Prevalence (%) and Patient Population, by Country, 2011 11
- Table 5: Insulin Delivery Devices Market, Global, Revenue ($bn), 2003-2010 16
- Table 6: Insulin Delivery Devices Market, Global, Revenue ($bn), 2010-2017 17
- Table 7: Insulin Pumps Market, Global, 2006-2010 19
- Table 8: Organizations/Companies Developing Artificial Pancreas 22
- Table 9: Annual Increase in the Incidence of Diabetes Among Children in Europe, 1983-2005 24
- Table 10: Studies Indicating Safety and Efficacy of Insulin Pumps 25
- Table 11: Studies Suggesting Higher Risk of Ketoacidosis from Insulin Pump Use, 2004 and 2009 27
- Table 12: Insulin Pens, Global, Revenue ($m), 2003-2010 29
- Table 13: Insulin Pens, Global, Revenue ($m), 2010-2017 30
- Table 14: Studies Suggesting Advantages of Insulin Pens Over Insulin Syringes, 2008-2011 31
- Table 15: Studies Suggesting Better Patient Compliance with Insulin Pens than Insulin Syringes, 2007-2010 33
- Table 16: Insulin Pumps, Global, Revenue ($m), 2003-2010 34
- Table 17: Insulin Pumps, Global, Revenue ($m), 2010-2017 35
- Table 18: Studies Indicating Safety and Efficacy of Insulin Pump Therapy in Pregnant Women, 2001-2011 36
- Table 19: Insulin Syringes, Global, Revenue ($m), 2003-2010 38
- Table 20: Insulin Syringes, Global, Revenue ($m), 2010-2017 39
- Table 21: Traditional Insulin Pump Accessories, Global, Revenue ($bn), 2003-2010 41
- Table 22: Traditional Insulin Pump Accessories, Global, Revenue ($bn), 2010-2017 42
- Table 23: Insulin Delivery Devices Market, The US, Revenue ($m), 2003-2010 43
- Table 24: Insulin Delivery Devices Market, The US, Revenue ($m), 2010-2017 44
- Table 25: Insulin Delivery Devices Market, Canada, Revenue ($m), 2003-2010 45
- Table 26: Insulin Delivery Devices Market, Canada, Revenue ($m), 2010-2017 46
- Table 27: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of <$15,000, June 2011 47
- Table 28: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $43,000, June 2011 48
- Table 29: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $75,000, June 2011 49
- Table 30: Insulin Delivery Devices Market, The UK, Revenue ($m), 2003-2010 50
- Table 31: Insulin Delivery Devices Market, The UK, Revenue ($m), 2010-2017 51
- Table 32: Insulin Delivery Devices Market, Germany, Revenue ($m), 2003-2010 52
- Table 33: Insulin Delivery Devices Market, Germany, Revenue ($m), 2010-2017 53
- Table 34: Insulin Delivery Devices Market, France, Revenue ($m), 2003-2010 54
- Table 35: Insulin Delivery Devices Market, France, Revenue ($m), 2010-2017 55
- Table 36: Insulin Delivery Devices Market, Italy, Revenue ($m), 2003-2010 56
- Table 37: Insulin Delivery Devices Market, Italy, Revenue ($m), 2010-2017 57
- Table 38: Insulin Delivery Devices Market, Spain, Revenue ($m), 2003-2010 58
- Table 39: Insulin Delivery Devices Market, Spain, Revenue ($m), 2010-2017 59
- Table 40: Insulin Delivery Devices Market, Japan, Revenue ($m), 2003-2010 60
- Table 41: Insulin Delivery Devices Market, Japan, Revenue ($m), 2010-2017 61
- Table 42: Insulin Delivery Devices Market, China, Revenue ($m), 2003-2010 62
- Table 43: Insulin Delivery Devices Market, China, Revenue ($m), 2010-2017 63
- Table 44: Insulin Delivery Devices Market, India, Revenue ($'000), 2003-2010 64
- Table 45: Insulin Delivery Devices Market, India, Revenue ($'000), 2010-2017 65
- Table 46: Insulin Delivery Devices Market, Australia, Revenue ($m), 2003-2010 66
- Table 47: Insulin Delivery Devices Market, Australia, Revenue ($m), 2010-2017 67
- Table 48: Insulin Delivery Devices Market, Brazil, Revenue ($m), 2003-2010 68
- Table 49: Insulin Delivery Devices Market, Brazil, Revenue ($m), 2010-2017 69
- Table 50: Insulin Delivery Devices Market, Global, Key Company Revenue ($m), 2010 70
- Table 51: Pipeline Products, Medtronic Inc. 72
- Table 52: Key Insulin Delivery Products, Medtronic Inc. 73
- Table 53: Key Insulin Delivery Products, Novo Nordisk A/S 75
- Table 54: Key Insulin Delivery Products, Sanofi 76
- Table 55: Key Insulin Delivery Products, Eli Lilly and Company 78
- Table 56: Insulin Delivery Devices, Becton, Dickinson and Company 79
- Table 57: Key Insulin Delivery Products, Becton, Dickinson and Company 79
- Table 58: Key Insulin Delivery Products, Disetronic Medical Systems AG 80
- Table 59: Insulin Delivery Devices, Pipeline Products by Stage of Development, 2011 81
- Table 60: Insulin Pumps, Pipeline by Developmental Stage and Territory, 2011 82
- Table 61: Artificial Pancreas System (Boston University), Clinical Trial Details 84
- Table 62: Artificial Pancreas System (University of Virginia), Clinical Trial Details 87
- Table 63: Paradigm Veo System, Clinical Trial Details 90
- Table 64: Insulin Pens, Pipeline by Developmental Stage and Territory, 2011 92
- Table 65: NovoPen Echo, Clinical Trial Details 92
- Table 66: Insulin Syringes, Pipeline by Developmental Stage and Territory, 2011 93
- Table 67: Other Insulin Delivery Devices, Pipeline by Developmental Stage and Territory, 2011 93
- Table 68: AFREZZA - Medtone Inhaler, Clinical Trial Details 94
- Table 69: Key Deals, Insulin Delivery Devices Market, 2009-2011 96
List of Figures
1.2 List of Figures
- Figure 1: Diabetes Prevalence (%), Global, 2011 11
- Figure 2: Insulin Delivery Devices, Market Segmentation 13
- Figure 3: Comparison of Insulin Delivery Devices 15
- Figure 4: Insulin Delivery Devices Market, Global, Revenue ($bn), 2003-2010 16
- Figure 5: Insulin Delivery Devices Market, Global, Revenue ($bn), 2010-2017 17
- Figure 6: Insulin Pumps Market, Global, 2006-2010 18
- Figure 7: Partnerships between Insulin Manufacturers and Insulin Delivery Device Companies 19
- Figure 8: Partnerships between Insulin Manufacturers and Insulin Delivery Device Companies 21
- Figure 9: Global Insulin Delivery Devices, Market Dynamics 24
- Figure 10: Causes of Type 1 Diabetes in Children 25
- Figure 11: Insulin Pens, Global, Revenue ($m), 2003-2010 29
- Figure 12: Insulin Pens, Global, Revenue ($m), 2010-2017 30
- Figure 13: Patient Perception Analysis for Insulin Pens and Insulin Syringes 32
- Figure 14: Insulin Pumps, Global, Revenue ($m), 2003-2010 34
- Figure 15: Insulin Pumps, Global, Revenue ($m), 2010-2017 35
- Figure 16: Insulin Syringes, Global, Revenue ($m), 2003-2010 38
- Figure 17: Insulin Syringes, Global, Revenue ($m), 2010-2017 39
- Figure 18: Traditional Insulin Pump Accessories, Global, Revenue ($bn), 2003-2010 41
- Figure 19: Traditional Insulin Pump Accessories, Global, Revenue ($bn), 2010-2017 42
- Figure 20: Insulin Delivery Devices Market, The US, Revenue ($m), 2003-2010 43
- Figure 21: Insulin Delivery Devices Market, The US, Revenue ($m), 2010-2017 44
- Figure 22: Insulin Delivery Devices Market, Canada, Revenue ($m), 2003-2010 45
- Figure 23: Insulin Delivery Devices Market, Canada, Revenue ($m), 2010-2017 46
- Figure 24: Individual Out-of-Pocket Expenses for Diabetes Management in Canadian Provinces with Annual Income of <$15,000, June 2011 47
- Figure 25: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $43,000, June 2011 48
- Figure 26: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $75,000, June 2011 49
- Figure 27: Insulin Delivery Devices Market, The UK, Revenue ($m), 2003-2010 50
- Figure 28: Insulin Delivery Devices Market, The UK, Revenue ($m), 2010-2017 51
- Figure 29: Insulin Delivery Devices Market, Germany, Revenue ($m), 2003-2010 52
- Figure 30: Insulin Delivery Devices Market, Germany, Revenue ($m), 2010-2017 53
- Figure 31: Insulin Delivery Devices Market, France, Revenue ($m), 2003-2010 54
- Figure 32: Insulin Delivery Devices Market, France, Revenue ($m), 2010-2017 55
- Figure 33: Insulin Delivery Devices Market, Italy, Revenue ($m), 2003-2010 56
- Figure 34: Insulin Delivery Devices Market, Italy, Revenue ($m), 2010-2017 57
- Figure 35: Insulin Delivery Devices Market, Spain, Revenue ($m), 2003-2010 58
- Figure 36: Insulin Delivery Devices Market, Spain, Revenue ($m), 2010-2017 59
- Figure 37: Insulin Delivery Devices Market, Japan, Revenue ($m), 2003-2010 60
- Figure 38: Insulin Delivery Devices Market, Japan, Revenue ($m), 2010-2017 61
- Figure 39: Insulin Delivery Devices Market, China, Revenue ($m), 2003-2010 62
- Figure 40: Insulin Delivery Devices Market, China, Revenue ($m), 2010-2017 63
- Figure 41: Insulin Delivery Devices Market, India, Revenue ($'000), 2003-2010 64
- Figure 42: Insulin Delivery Devices Market, India, Revenue ($'000), 2010-2017 65
- Figure 43: Insulin Delivery Devices Market, Australia, Revenue ($m), 2003-2010 66
- Figure 44: Insulin Delivery Devices Market, Australia, Revenue ($m), 2010-2017 67
- Figure 45: Insulin Delivery Devices Market, Brazil, Revenue ($m), 2003-2010 68
- Figure 46: Insulin Delivery Devices Market, Brazil, Revenue ($m), 2010-2017 69
- Figure 47: Insulin Delivery Devices Market, Global, Key Company Share (%), 2010 70
- Figure 48: Insulin Delivery Devices Market, Competitive Assessment 71
- Figure 49: Insulin Delivery Devices, Pipeline Products by Stage of Development, 2011 81
- Figure 50: Insulin Pumps, Pipeline Assessment by Developmental Stage, 2011 82
胰島素輸送裝置 - 糖尿病患病率的增加牽引了市場
2012年01月20日
環球訊息股份有限公司開始販賣GlobalData所發行的報告書「Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 (胰島素給藥設備:全球開發平台分析機會評估及與到2017年為止的市場預測)」。
Globaldata推測2010年的全球胰島素輸送裝置市場達到74億美元規模。
糖尿病患病率大幅增加、胰島素輸送裝置的償還、以及肯定性臨床結果讓該同市場以複合年度成長率（CAGR）6%擴大、2017年預估可超過110億美元
美國是最大的胰島素輸送裝置市場、2010年市場規模為28億美元。之後以CAGR 6%成長、2017年終將達到42億美元。
這個成長的主要原因包含了所有年齡層中的糖尿病患病率增加、胰島素幫浦的高市場浸透率、以及保險償還制度等要因。
胰島素幫浦，比起歐洲各國，在美國貝更一般性的使用著。
2010年5月所發行的Journal of Diabetes Science and Technology的記事中，胰島素幫浦在美國的胰島素輸送中被利用較多，而在歐洲，常用的則是胰島素筆。
Juvenile Diabetes Research Federation (JDRF)進一步提到了在美國，約有40萬人的１型糖尿病患者在使用胰島素筆。
|
 |
